1 / 10

Hsia J et al. J Am Coll Cardiol 2011;57:1666-75

Hsia J et al. J Am Coll Cardiol 2011;57:1666-75. Baseline Characteristics by Treatment Group and Attained LDL-C . Hsia J et al. J Am Coll Cardiol 2011;57:1666-75. Independent Predictors of Attaining LDL-C <50 mg/dl at Any Visit Among Rosuvastatin-Allocated Patients .

kele
Download Presentation

Hsia J et al. J Am Coll Cardiol 2011;57:1666-75

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Hsia J et al. J Am Coll Cardiol 2011;57:1666-75

  2. Baseline Characteristics by Treatment Group and Attained LDL-C Hsia J et al. J Am Coll Cardiol 2011;57:1666-75

  3. Independent Predictors of Attaining LDL-C <50 mg/dl at Any Visit Among Rosuvastatin-Allocated Patients Hsia J et al. J Am Coll Cardiol 2011;57:1666-75

  4. Cardiovascular Events and All-Cause Mortality by Baseline LDL-C Level Hsia J et al. J Am Coll Cardiol 2011;57:1666-75

  5. Time to Occurrence of Major Cardiovascular Events According to Treatment Group and Achieved LDL-C Concentrations Hsia J et al. J Am Coll Cardiol 2011;57:1666-75

  6. Primary Endpoint in Pre-Specified Subgroups Within JUPITER Trial, Stratified by Achieved LDL-C Hsia J et al. J Am Coll Cardiol 2011;57:1666-75

  7. Fully-Adjusted Hazard Ratios for Incident Cardiovascular Events and All-Cause Mortality According to Treatment Group and Achieved Concentrations of LDL-C Hsia J et al. J Am Coll Cardiol 2011;57:1666-75

  8. Numbers and Rates (per 100 Person-Years) of Treatment-Emergent Adverse Events by Treatment Group and Attained LDL-C Hsia J et al. J Am Coll Cardiol 2011;57:1666-75

  9. ALT or CK Elevation, Proteinuria, or Hematuria at Any Follow-Up Visit by Treatment Assignment and Attained LDL-C Hsia J et al. J Am Coll Cardiol 2011;57:1666-75

  10. Relation of Major Cardiovascular Event Rate to LDL-C at 1 Year in Primary Prevention Trials Hsia J et al. J Am Coll Cardiol 2011;57:1666-75

More Related